Loading...

Loading...

COVID-19 Vaccine, Test Kits Among TIME’s Best Inventions of 2021
By Miriam Bello - Wed, 11/17/2021 - 13:30
TIME’s “The 100 best inventions of 2021” lists several disruptive healthcare products. Read more about them here.
https://mexicobusiness.news/tag/constanza-losada
More Health
R&D Investment for Economic Sustainability, Access to Therapies
By Miriam Bello - Thu, 08/26/2021 - 11:30
Mexico’s R&D capabilities could boost the pharma industry’s economic position while spurring local technology development.
Key Steps for the Efficient Delivery of COVID-19 Vaccines
By Miriam Bello - Wed, 07/14/2021 - 18:40
The safe and efficient delivery of COVID-19 vaccines involves a complex, careful process at every step of the supply chain. Read more here.
Benchmark of Innovation Delivers First COVID-19 Vaccine
By Miriam Bello - Mon, 07/12/2021 - 14:58
Pfizer’s innovations help ensure global health. In the midst of a pandemic, the pharmaceutical company continues to demonstrate leadership.
The Voices of Female Leadership
By Miriam Bello - Mon, 03/08/2021 - 17:42
Equality at the workplace is still a long road ahead. However, Mexico does have outstanding female leaders in the health sector.
Positive Results for Pfizer’s COVID-19 Vaccine
By Miriam Bello - Mon, 11/09/2020 - 14:10
The Pfizer and BioNTech joint venture for a COVID-19 vaccine has announced a 90 percent effectiveness in its solution.
Women in Healthcare: Constanza Losada
By Miriam Bello - Wed, 09/02/2020 - 10:12
We interviewed the President and Country Manager of Pfizer to learn about her experience as a woman in the sector.
A United Response From the Healthcare Industry in Mexico
By Miriam Bello - Tue, 06/23/2020 - 12:40
From the frontline of the pandemic to the vaccine race, the healthcare industry in Mexico has worked nonstop over these past months.
Pfizer: COVID-19 Vaccine Trials Demonstrate Leadership
By Miriam Bello - Mon, 06/22/2020 - 09:42
Constanza Losada, the company’s new President and Country Manager, talks about Pfizer’s leadership and goals.